Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer
The purpose of this study to find out whether a very low carbohydrate diet (ketogenic diet), a low carbohydrate diet, or the study drug canagliflozin can prevent high blood sugar and may improve the effectiveness of cancer therapy in people who are receiving standard treatment with alpelisib and fulvestrant for their metastatic PIK3CA-mutant breast cancer.
Breast Cancer|Breast Cancer Stage IV|Metastatic Breast Cancer
DIETARY_SUPPLEMENT: Ketogenic Diet|DIETARY_SUPPLEMENT: Low Carbohydrate Diet|DRUG: Alpelisib|DRUG: Fulvestrant|DRUG: Canagliflozin
Hyperglycemia-free rate for participants, To determine the grade 3/4 hyperglycemia-free rate at 12 weeks, as assessed by the NCI CTCAE v5.0, 12 weeks
The purpose of this study to find out whether a very low carbohydrate diet (ketogenic diet), a low carbohydrate diet, or the study drug canagliflozin can prevent high blood sugar and may improve the effectiveness of cancer therapy in people who are receiving standard treatment with alpelisib and fulvestrant for their metastatic PIK3CA-mutant breast cancer.